Long-term safety and effectiveness of natalizumab treatment in clinical practice: 10 years of real-world data from the Tysabri Observational Program (TOP)

OBJECTIVE: The Tysabri Observational Programme (TOP), which began >10 years ago, is an open-label, multinational, prospective observational study evaluating the long-term safety and effectiveness of natalizumab in relapsing-remitting multiple sclerosis patients. METHODS: These data provide a 10-y...

Descripción completa

Detalles Bibliográficos
Autores principales: Butzkueven, Helmut, Kappos, Ludwig, Wiendl, Heinz, Trojano, Maria, Spelman, Tim, Chang, Ih, Kasliwal, Rachna, Jaitly, Seema, Campbell, Nolan, Ho, Pei-Ran, Licata, Stephanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Multiple Sclerosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279201/
https://www.ncbi.nlm.nih.gov/pubmed/32234967
http://dx.doi.org/10.1136/jnnp-2019-322326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279201/
https://www.ncbi.nlm.nih.gov/pubmed/32234967
http://dx.doi.org/10.1136/jnnp-2019-322326

Ejemplares similares